Breaking new ground in anti-infectives

 

Published in March 2015.

ABIVAX is bringing novel antiviral compounds and human vaccines to patients worldwide through a combination of in-house biotechnology expertise and Cuban life science research.

 

Click here to view complete article or download pdf. 

 

Press contacts

Caroline Carmagnol 

abivax@alizerp.com

+ 33 6 64 18 99 59 or
+ 33 1 44 54 36 65

 Standard: +33 1 53 83 08 41

More articles in French

Click here